About CorNeat Vision
CorNeat Vision is a company based in Raanana (Israel) founded in 2015 by Gilad Litvin. CorNeat Vision has raised $4 million across 3 funding rounds from investors including European Union, GIBF and EIC Fund. CorNeat Vision offers products and services including CorNeat KPro, eShunt, and EverPatch+. CorNeat Vision operates in a competitive market with competitors including CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others.
- Headquarter Raanana, Israel
- Founders Gilad Litvin
- SectorsTechnologyHealthcare
- Email••••••••
- Phone•••• ••••
- Website corneat.com
- Social LinkedIn X YouTube
- Total Equity Funding$4M (USD)
in 3 rounds
- Latest Funding Round$2.73M (USD), Grant
Feb 2022
- InvestorsEuropean Union
& 2 more
Products & Services of CorNeat Vision
CorNeat Vision offers a comprehensive portfolio of products and services, including CorNeat KPro, eShunt, and EverPatch+.
Implant for treating corneal blindness by integrating with eye tissue.
Minimally invasive drainage device for glaucoma surgery.
Permanent matrix for reinforcing ocular surfaces and repairs.
Apps and channels of CorNeat Vision
its YouTube channel CorNeat Vision has 829 subscribers and 21 videos.
Videos from CorNeat Vision
The most watched videos on CorNeat Vision's YouTube channel, CorNeat Vision (829 subscribers). Click a video to play it here.
More on CorNeat Vision.
Funding Insights of CorNeat Vision
CorNeat Vision has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.73 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4M
- Total Rounds 3
- Last Round Grant — $2.73M
- First Round $56,630
(Jun 2021)
- Investors Count 3
All 3 funding rounds of CorNeat Vision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $2.73M | Grant | – | – | |
| Aug 2021 | $4M | Series A | – | GIBF | – |
| Jun 2021 | $56,630 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in CorNeat Vision
CorNeat Vision has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, GIBF and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | gibf-bio.com | - | |
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for CorNeat Vision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CorNeat Vision
2 people are tracked at CorNeat Vision (2 in leadership).
| Name | Role | Group |
|---|---|---|
Gilad Litvin | Founder & CMO | Leadership |
Almog Aley raz | CEO | Leadership |
Complete people profiles for CorNeat Vision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CorNeat Vision
3 dated milestones of CorNeat Vision across 7 years, from founding to its latest funding, stage changes and deals.
- Founded CorNeat Vision is founded.
- Funding First funding round of $57K.
- Funding Latest funding round, Grant, of $2.7M.
Competitors of CorNeat Vision
CorNeat Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| corneagen.com | 2017 | Seattle, United States | $42M | 205 | Therapeutic devices for corneal transplants are developed by CorneaGen. | |
| satellite.bio | 2019 | Cambridge, United States | $110M | 21 | Proprietary implantable satellite organs are developed for cell therapy. | |
| avedro.com | 2007 | Waltham, United States | $210.76M | 113 | Corneal collagen cross-linking technology is developed for ophthalmic applications. | |
| eyegatepharma.com | 1998 | Waltham, United States | $44.47M | 12 | Therapeutics and drug delivery systems for eye diseases are developed. | |
| kalocyte.com | 2016 | St. Louis, United States | $1.1M | – | Nanotechnology-based red blood cell substitutes are developed. | |
| cellusion.jp | 2015 | Minato, Japan | $29.71M | – | iPS cell-based technology for corneal endothelium regeneration is developed. | |
| eye-yon.com | 2011 | Ness Ziona, Israel | $35.1M | – | Ophthalmic devices for corneal edema treatment are developed. | |
| promimic.com | 2004 | Gothenburg, Sweden | $4.75M | – | Biomaterial coating for artificial implants | |
| stratatechcorp.com | 2000 | United States | $3.68M | 47 | Cell-based skin substitutes are developed for therapeutic and research uses. |
Detailed competitors of CorNeat Vision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CorNeat Vision
The website of CorNeat Vision (corneat.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 11.3% vs previous month
Latest news on Corneat Vision
Complete news archive for CorNeat Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CorNeat Vision
10 companies that operate in the same segment as CorNeat Vision (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CorNeat Vision
CorNeat Vision was founded in 2015 and raised its 1st funding round 6 years after it was founded.
CorNeat Vision is headquartered in Raanana, Israel. It is registered at Raanana, Central District, Israel.
Almog Aley raz is the current CEO of CorNeat Vision.
CorNeat Vision is a funded company, having raised a total of $4M across 3 funding rounds to date. The company's 1st funding round was a Grant of $56.63K, raised on Jun 2021.
CorNeat Vision was founded in 2015 as a developer of nanotechnology-based artificial corneal implants. Nano-cell technology is employed in these synthetic corneas, which can be integrated with artificial optics. The product line, including CorNeat KPro and CorNeat EverPatch, is designed for ophthalmic surgeries addressing cornea, sclera, glaucoma trabecular mesh, myopia, and related areas. Operations focus on medical device innovation in the biotechnology sector.
CorNeat Vision offers CorNeat KPro, eShunt, and EverPatch+.
CorNeat Vision has 3 investors. Key investors include European Union, GIBF, and EIC Fund.